PureTech Health plc
PTCHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.05 | -0.36 | 1.24 | 0.02 |
| FCF Yield | -27.00% | -13.63% | -20.28% | -15.46% |
| EV / EBITDA | 6.41 | -52.71 | -15.13 | 24.25 |
| Quality | ||||
| ROIC | -27.95% | -41.53% | -12.78% | -21.92% |
| Gross Margin | 26.04% | -48.14% | -6,546.17% | -1,007.03% |
| Cash Conversion Ratio | -4.84 | 1.61 | 4.82 | 2.52 |
| Growth | ||||
| Revenue 3-Year CAGR | 32.19% | -30.64% | -36.96% | 4.73% |
| Free Cash Flow Growth | -26.58% | 41.34% | -10.39% | -19.44% |
| Safety | ||||
| Net Debt / EBITDA | -6.91 | 14.25 | 1.97 | -15.47 |
| Interest Coverage | -13.56 | -10.84 | -50.04 | -31.88 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 3.95 |
| Cash Conversion Cycle | 975.48 | -822.51 | 3,840.99 | 186.30 |